Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2025 05:00 ET | Source: Isarna Therapeutics

Isarna Therapeutics Presents Positive Phase 2 BETTER Trial Final Results at ARVO 2025

Innovative antisense therapy blocking production of TGF-β2 shows promise in reducing retinal fibrosis and improving outcomes in patients with wet AMD and DME Gräfelfing, Germany, May 7th, 2025 –...